INNOVATE & COLLABORATE
THIS IS WHAT WE DO
At Cuprous, we specialize in developing technologies that result in the creation of novel, best-in-class small molecules by overcoming developmental barriers and improving safety and therapeutic activity.
DEVELOPMENT AND CHARACTERIZATION OF A NOVEL FLAVOPIRIDOL FORMULATION FOR TREATMENT OF ACUTE MYELOID LEUKEMIA
March 30, 2021
Cuprous' Metaplex Technology has been used to develop a Flavopiridol formulation that provides a 30-fold increase in plasma AUC and an associated increase in therapeutic activity in models of AML.